Recommendations for the COVID-19 Vaccine in IBD

January 21st, 2021

Get the latest updates on COVID-19 in Canada, and recommendations for vaccine use in people living with Crohn's or colitis. Experts discuss the impact of medication, pregnancy, and disease severity on the safety and efficacy of the vaccine.

  • Panel Members

    Dr. Cynthia Seow (MBBS, MSc, FRACP), Pregnancy and IBD Specialist, Associate Professor, Division of Gastroenterology and Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary

    Dr. Charles Bernstein (MD, FRCPC), Distinguished Professor of Medicine, Gastroenterologist, Faculty of Medicine, Bingham Chair in Gastroenterology Research, University of Manitoba

    Moderators

    Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Past Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada l Twitter: @gilkaplan

    Dr. Eric Benchimol (MD, PhD, FRCPC), Professor, Pediatric Gastroenterologist, Department of Paediatrics, The Hospital for Sick Children (SickKids) and University of Toronto, Division of Gastroenterology, Hepatology and Nutrition, SickKids, NASPGHAN Canadian Councilor, Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada | Twitter: @ericbenchimol


If you require further assistance, please click here to contact us.

Dr Benchimol and Dr Kaplan photos

Want to help boost our research initiatives?

Text CURE to 20222 to donate $25 to Crohn’s and Colitis Canada’s critical research projects.

READ MORE

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.